Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVORAL 2 oral buccal insulin spray in impaired glucose tolerance
2009-016022-14Phase 2Active
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human insulin in prediabetes and hyperglycemia (2 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoints: Change in HbA1c at 6 months, Glucose variability by CGMS at 3 and 6 months and 1 more. Started Oct 2009; status: active.
02
Drugs
human insulin
03
Conditions
prediabeteshyperglycemia
Beyond the preview
Go deeper on 2009-016022-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016022-14.